מחיר ריאלי לרכישת החברה במלואה: 23andMe Inc (ME)

23andMe Holding Co. (ME) possesses a unique array of genetic data and patents protected by strict FDA oversight. The business relies on automated DNA processing lines that replace manual labor. This price chart demonstrates an Enterprise Value of . The company is currently implementing cloud-based AI systems for high-precision analysis of customer profiles and the automated identification of medical risks.

23andMe Holding Co. (ME) expenditures on cybersecurity and digital sovereignty compliance directly impact its capital structure, as reflected in the calculated enterprise value. This indicator aggregates market capitalization and net debt to determine the total cost of acquiring the business, and its dynamics allow investors to assess the real price of assets while accounting for debt load and liquidity.